This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

While visiting Utah, Christine Seppi experienced sudden, severe abdominal and back pain. A rare diagnosis—an abdominal aortic ...

The study found that early intervention led to an 80% reduction in heart failure hospitalisations one year after treatment.

The data highlighted that delayed aortic valve replacement in this patient ... including MITRIS, INSPIRIS, and KONECT. We continue to generate high-quality evidence on our RESILIA tissue technology.

Transcatheter Aortic Valve Replacement (TAVR ... with Edwards’ premium RESILIA tissue portfolio including MITRIS, INSPIRIS and KONECT. Also in the first quarter, Edwards made progress advancing ...

“Given that TAVR is mounted on a flexible stent, unlike Inspiris with Resilia tissue mounted on a rigid surgical valve frame, we will need to determine the long-term outcomes of Resilia in a ...

To create a more durable heart valve, Edwards developed the RESILIA tissue technology more than two decades ago. Today, RESILIA tissue is used in a wide range of Edwards’ surgical and transcatheter ...

Today, RESILIA tissue is used in a wide range of Edwards’ surgical and transcatheter platforms, including the INSPIRIS RESILIA aortic surgical valve, the KONECT RESILIA aortic surgical valve ...

Surgical aortic valve replacement (SAVR ... We performed SAVR with a bioprosthetic valve (INSPIRIS RESILIA 19 mm, Edwards Lifesciences, Irvine, CA, USA) and assessed serial MRI in three symptomatic ...

Get Instant Summarized Text (Gist) A new transcatheter valve, the Trilogy system, has demonstrated safety and efficacy in treating aortic regurgitation, with a one-year mortality rate of 8.1% ...